Home » Skin News

Acne Scars Study – Isolagen Reports Positive Results From Phase II/III

No Comment


Research

Research

PHARMACEUTICAL BUSINESS REVIEW — Mar 9 — Isolagen, an aesthetic and therapeutic company, has announced positive top-line efficacy results from a Phase II/III clinical study of the Isolagen Therapy for the treatment of moderate to severe acne scars.

According to Isolagen, the study met all primary efficacy endpoints and was statistically significant, making this a major clinical milestone for the company.
READ FULL ARTICLE @ PHARMACEUTICAL BUSINESS REVIEW

Pages: 1 2

No related writeups.

   Email This Article

This website uses IntenseDebate comments, but they are not currently loaded because either your browser doesn't support JavaScript, or they didn't load fast enough.

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.